148 related articles for article (PubMed ID: 8463132)
1. Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression.
Kishi M; Nishino Y; Ohki K; Kimura T; Ikuta K
Jpn J Cancer Res; 1993 Feb; 84(2):153-62. PubMed ID: 8463132
[TBL] [Abstract][Full Text] [Related]
2. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
[TBL] [Abstract][Full Text] [Related]
3. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
Poon B; Chang MA; Chen IS
J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
[TBL] [Abstract][Full Text] [Related]
4. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K
J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943
[TBL] [Abstract][Full Text] [Related]
5. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
6. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
Schwartz S; Felber BK; Pavlakis GN
Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
[TBL] [Abstract][Full Text] [Related]
7. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.
Chen BK; Gandhi RT; Baltimore D
J Virol; 1996 Sep; 70(9):6044-53. PubMed ID: 8709227
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Vpr protein does not modulate surface expression of the CD4 receptor.
Argañaraz E; Cortés MJ; Leibel S; Lama J
J Virol; 2002 Apr; 76(8):4125-30. PubMed ID: 11907254
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.
Benson RE; Sanfridson A; Ottinger JS; Doyle C; Cullen BR
J Exp Med; 1993 Jun; 177(6):1561-6. PubMed ID: 8098729
[TBL] [Abstract][Full Text] [Related]
10. Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells.
Geleziunas R; Bour S; Wainberg MA
J Gen Virol; 1994 Apr; 75 ( Pt 4)():857-65. PubMed ID: 8151301
[TBL] [Abstract][Full Text] [Related]
11. Impairment of human immunodeficiency virus type 1 (HIV-1) entry into Jurkat T cells by constitutive expression of the HIV-1 vpr protein: role of CD4 down-modulation.
Conti L; Varano B; Gauzzi MC; Matarrese P; Federico M; Malorni W; Belardelli F; Gessani S
J Virol; 2000 Nov; 74(21):10207-11. PubMed ID: 11024150
[TBL] [Abstract][Full Text] [Related]
12. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.
Nishino Y; Kishi M; Sumiya M; Ogawa K; Adachi A; Maotani-Imai K; Kato S; Hirai K; Ikuta K
Arch Virol; 1991; 120(3-4):181-92. PubMed ID: 1835572
[TBL] [Abstract][Full Text] [Related]
14. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB
J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859
[TBL] [Abstract][Full Text] [Related]
15. Superinfection of a defective human immunodeficiency virus type 1 provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination.
Kishi M; Tokunaga K; Zheng YH; Bahmani MK; Kakinuma M; Nonoyama M; Lai PK; Ikuta K
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):45-53. PubMed ID: 7734196
[TBL] [Abstract][Full Text] [Related]
16. An infectious DNA clone of HIV type 1 subtype C.
Mochizuki N; Otsuka N; Matsuo K; Shiino T; Kojima A; Kurata T; Sakai K; Yamamoto N; Isomura S; Dhole TN; Takebe Y; Matsuda M; Tatsumi M
AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1321-4. PubMed ID: 10505681
[TBL] [Abstract][Full Text] [Related]
17. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
[TBL] [Abstract][Full Text] [Related]
18. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
Wildum S; Schindler M; Münch J; Kirchhoff F
J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
